Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Priyambada, L; Wolfsdorf, JI; Brink, SJ; Fritsch, M; Codner, E; Donaghue, KC; Craig, ME.
ISPAD Clinical Practice Consensus Guideline: Diabetic ketoacidosis in the time of COVID-19 and resource-limited settings-role of subcutaneous insulin.
Pediatr Diabetes. 2020; 21(8):1394-1402
Doi: 10.1111/pedi.13118
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Fritsch Maria
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guideline 2018 for management of diabetic ketoacidosis (DKA) and the hyperglycemic hyperosmolar state provide comprehensive guidance for management of DKA in young people. Intravenous (IV) infusion of insulin remains the treatment of choice for treating DKA; however, the policy of many hospitals around the world requires admission to an intensive care unit (ICU) for IV insulin infusion. During the coronavirus 2019 (COVID-19) pandemic or other settings where intensive care resources are limited, ICU services may need to be prioritized or may not be appropriate due to risk of transmission of infection to young people with type 1 or type 2 diabetes. The aim of this guideline, which should be used in conjunction with the ISPAD 2018 guidelines, is to ensure that young individuals with DKA receive management according to best evidence in the context of limited ICU resources. Specifically, this guideline summarizes evidence for the role of subcutaneous insulin in treatment of uncomplicated mild to moderate DKA in young people and may be implemented if administration of IV insulin is not an option. © 2020 John Wiley & Sons A/S . Published by John Wiley & Sons Ltd.
- Find related publications in this database (using NLM MeSH Indexing)
- Adolescent -
- Betacoronavirus -
- COVID-19 -
- Child -
- Comorbidity -
- Consensus -
- Coronavirus Infections - epidemiology
- Coronavirus Infections - prevention & control
- Diabetes Mellitus, Type 1 - drug therapy
- Diabetes Mellitus, Type 1 - epidemiology
- Diabetes Mellitus, Type 2 - drug therapy
- Diabetes Mellitus, Type 2 - epidemiology
- Diabetic Ketoacidosis - drug therapy
- Diabetic Ketoacidosis - epidemiology
- Humans -
- Hypoglycemic Agents -
- Infusions, Intravenous -
- Injections, Intramuscular -
- Injections, Subcutaneous -
- Insulin, Short-Acting - administration & dosage
- Insulins - administration & dosage
- Intensive Care Units -
- Pandemics - prevention & control
- Pneumonia, Viral - epidemiology
- Pneumonia, Viral - prevention & control
- SARS-CoV-2 -
- Young Adult -
- Find related publications in this database (Keywords)
- COVID-19
- diabetic ketoacidosis
- resource-limited settings
- subcutaneous insulin